🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immune response analysis after the combination of PCV13 and PPV23 will lead...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-04
Trial ID
NCT02279589
Treatments Being Tested
The purpose of this observer-blind study is to evaluate the safety, reactog...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-19
Trial ID
NCT00756067
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity and imm...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-30
Trial ID
NCT00707798
Treatments Being Tested
Streptococcus pneumoniae is the major cause of bacterial infection in patie...
Status
Completed
Location
Henri Mondor Hospital
Start Date
2013-09-16
Trial ID
NCT02274415
As the licensed pneumococcal vaccine is not always satisfactory in elderly,...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05-01
Trial ID
NCT00327665
The primary objectives of this study were to assess the immunogenicity and ...
Status
Terminated
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00368186
Treatments Being Tested
To compare the ability of Prevnar® to Pneumo® 23 in reducing and preventing...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT00580684
Treatments Being Tested
This is a multicenter, prospective, randomized, open study comparing two an...
Status
Terminated
Location
CHU Amiens-Picardie
Start Date
2015-04-13
Trial ID
NCT02255227
Treatments Being Tested
Evaluate the immunological memory induced by 4 doses of GSK Biologicals' 11...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03
Trial ID
NCT00169507
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, reactogenicity a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-05
Trial ID
NCT02045836